ProtoKinetix owns the world-wide rights to a family of anti-aging glycoproteins, trademarked as AAGPs™. In clinical tests AAGPs™ have demonstrated the ability to enhance the health and extend the life of biologically sensitive cells which have been subjected to severe stress conditions under laboratory controlled tests. AAGPs™ are stable and non-toxic.
News Feb 01, 2008
A study published today in the journal Stem Cell Reports suggests that a combination of two clinically approved drugs – Viagra and Plerixafor – efficiently and rapidly mobilizes blood stem cells from the bone marrow into the bloodstream in a mouse model. This combination therapy may offer a new approach for bone marrow transplants in humans.
A stem cell transplant reversed a debilitating neurological disease that causes half of the patients to go blind and lose the ability to walk five years after diagnosis. Most of the patients stayed better five years after the transplant and were able to avoid drug treatment that cost up to $500,000 yearly, reports a new study.READ MORE